Inflammatory mechanisms contributing to pancreatic cancer development.
about
Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 proteinK-ras and Dpc4 mutations in chronic pancreatitis: case seriesMicrobial pigments as natural color sources: current trends and future perspectivesExploiting inflammation for therapeutic gain in pancreatic cancerAn Overview of Genetic Changes and Risk of Pancreatic Ductal AdenocarcinomaImmunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis.High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo.Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumorAnti-Inflammatory Agents for Cancer Therapy.Comparative analysis of clinicopathological correlations of cyclooxygenase-2 expression in resectable pancreatic cancerHelicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients.Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer.Thymosin beta-10 is aberrantly expressed in pancreatic cancer and induces JNK activationThymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activationInterleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancerAssociation studies of the copy-number variable ß-defensin cluster on 8p23.1 in adenocarcinoma and chronic pancreatitis.Risk factors for pancreatic cancer: case-control studySpongiatriol inhibits nuclear factor kappa B activation and induces apoptosis in pancreatic cancer cellsDiscovering the route from inflammation to pancreatic cancer.Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.Pancreatitis and pancreatic cancer in two large pooled case-control studies.Inflammation-related gene variants as risk factors for pancreatic cancer.ABO blood group and chronic pancreatitis risk in the NAPS2 cohort.Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis.Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review.Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice.Pancreatic cancer-associated stroma productionThe role of nitric oxide in mediating tumour blood flow.Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values.The role of death receptor ligands in shaping tumor microenvironment.Molecular mechanisms of pancreatic cancer and potential targets of treatment.Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression.Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancerInflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohortsApoptotic pathways in pancreatic ductal adenocarcinomaElimination of the biphasic pharmacodynamics of 15d-PGJ2 by controlling its release from a nanoemulsion.Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic TumorsRosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer.Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer.
P2860
Q24314713-01B2F643-6646-460C-81A0-13920833DAA3Q24676729-63A3AA6D-4D10-4262-BB11-2AE47A60C417Q26798836-BAAD5B08-C075-4FD4-B583-B5FA43C3704CQ27027661-F75DB355-FEE5-45C4-B80D-04CEBCF6E3F5Q28076342-E0EE0C54-0B39-4606-9F50-A876754E97BDQ30481528-841E16A7-EF8A-413C-817D-409B59799CE0Q30884835-11AF1AB6-533F-4722-B31F-CDDA4B14758EQ33538894-D0B5C0F6-94BA-4BA8-B08B-47F13721D461Q33728439-82C3AC7A-A44D-459A-9CC8-C2B6940647AEQ33744129-6B7A3D9D-FBF8-47C1-BB70-DD1D67AC89C0Q33798878-79CC3364-13E3-4791-8526-9196D597E701Q34012940-C8DFEAD5-C39C-4E6E-A669-93D7338ED4C3Q34014091-55FFD6C5-8F97-4232-BB90-40D49AF17E28Q34088815-18C5CBB2-DEFB-4F0A-84A7-4FF22F21C874Q34091336-3C3FA2C2-9DFE-4583-8A55-812BAEFF359FQ34091347-9C95624D-2BB2-4B8F-A103-D84AC090DC7AQ34475611-6B82992D-5BB4-410D-BE8B-30EB1400AE7CQ34582332-B8878F4A-6718-41A4-B3AA-121E02D55C5CQ34645863-845154C3-D3DC-4BC6-AE90-99299F503F9DQ34645978-6A94CEF3-7F35-4E8F-A3B7-314829C7E844Q34656874-CD0602A8-4AE5-485D-878A-8A3B248CD6CEQ35003467-4CBF3A8E-AD4E-478C-9D36-62FAB79EA7B4Q35036385-3F0EE0F3-EC8D-4E5F-9915-AEF3EC6F9692Q35376422-5C558E90-5CB3-4466-B143-4286DB749F60Q35659991-D0E39F2D-244C-4AC0-8B64-ADD2CA027FC3Q36015280-ADE3A201-8021-49CD-B230-6FA92FE252A0Q36143628-593CC9B4-AFFE-4B22-8709-80CEAAAD3860Q36168805-0AC33F19-EEF4-48F7-A342-1F3A55A94E8DQ36596676-722BCE62-CFD6-4E9A-A701-1D6E38C96824Q36659818-339BE65F-2CF9-4AF5-A310-5A5C87112B3BQ36693120-40E23B47-E207-4F23-9263-375CB40489E6Q36758436-A7EFD6D0-9700-48FE-939C-5C47CEC22ECEQ36787635-B0F51194-72F1-4B44-A447-58F64C8F4FDBQ36825610-D1E210D6-2802-400B-99CC-ADE74139F6FBQ36831927-E9793528-B542-4C2B-AD63-20CFA0324693Q36835642-F8D2A49F-B670-4B26-9634-48167324A294Q37003839-D86A54B4-1084-42FA-911F-A684F44D1C40Q37017121-D1388357-8137-4E92-82AC-E0A0C661474EQ37415843-5C4D1EE5-7A10-46C7-8F4A-3ADC6E7384FFQ37947960-DA6BEB30-4015-465C-92A3-0FD7D7C606B9
P2860
Inflammatory mechanisms contributing to pancreatic cancer development.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Inflammatory mechanisms contributing to pancreatic cancer development.
@ast
Inflammatory mechanisms contributing to pancreatic cancer development.
@en
type
label
Inflammatory mechanisms contributing to pancreatic cancer development.
@ast
Inflammatory mechanisms contributing to pancreatic cancer development.
@en
prefLabel
Inflammatory mechanisms contributing to pancreatic cancer development.
@ast
Inflammatory mechanisms contributing to pancreatic cancer development.
@en
P2093
P2860
P1433
P1476
Inflammatory mechanisms contributing to pancreatic cancer development.
@en
P2093
B Mark Evers
Buckminster Farrow
Ekong Uffort
William Nealon
Yuko Sugiyama
P2860
P304
763-9; discussion 769-71
P356
10.1097/01.SLA.0000128681.76786.07
P407
P577
2004-06-01T00:00:00Z